CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 62,823	$ 70,643
Research and development incentive receivable	780	771
Prepaid expenses and other current assets	209	183
Total current assets	63,812	71,597
Property and equipment, net		5
Right of use assets, net	370	257
Deposits	865	966
Total assets	65,047	72,825
Current liabilities:
Accounts payable	5,946	6,465
Accrued expenses	9,049	5,957
Income tax payable	722
Lease liability - current portion	376	262
Total current liabilities	16,093	12,684
Total liabilities	16,093	12,684
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $0.001 par value; 240,000,000 shares authorized; 38,264,464 and 25,565,414 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively	38	26
Additional paid-in capital	500,850	459,591
Accumulated other comprehensive income	6	106
Accumulated deficit	(451,940)	(399,582)
Total stockholders' equity	48,954	60,141
Total liabilities and stockholders' equity	$ 65,047	$ 72,825